Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CO2 GRO Inc V.GROW

Alternate Symbol(s):  BLONF

CO2 GRO Inc. is a Canada-based precision ag-tech company. The Company is focused on delivering carbon dioxide (CO2) delivery solutions to the global protected agricultural sector. Its patented technology provides the service of C-stainable crop production and pathogen perimeter protection for healthier crops by enriching plants with CO2 via an aqueous CO2 microfilm on the leaf surface. About 300 million metric ton (MT) of fruit and vegetables are grown annually from about five million hectares of protected vegetable facilities globally. The Company operates in Canada, the United States and the European Union. The Company's subsidiary is CO2 GRO (US) Inc.


TSXV:GROW - Post by User

Comment by Charlespon Aug 29, 2022 8:29pm
189 Views
Post# 34928371

RE:Sales target is meaningless

RE:Sales target is meaninglessWhat you are asking has no impact what soo ever. Stop losing time of the company for your insecurity. Sales is the amount of the contract sign and revenue is the payment received.... This is very transparent When revenu stream will really start it will only go higher and higher every quarter.
lscfa wrote:

Sales is not equal to revenues. Without knowing the timing of Instalment payments revenues can not be estimated. Co. must provide guidance on revenues and not just sales!!!  


 

$1.5M-$2.5M 2022 Sales Target Unchanged

For Q2 2022, our recorded revenue was $NIL and deferred revenue was US$27,750 from the now installed US$127,750 Commercial Technology Purchase ("contracted sale" or "sale") announced in Q1 2022. The balance of US$100,000 will be paid in four equal payments of US$25,000 every 4 months starting December 1, 2022. Proceeds from a second contracted sale to Hidroexpo late in Q2 2022 are not yet recorded in either revenue or deferred revenue.

Our unchanged contracted sales forecast of $1.5M-$2.5M are expected to be secured in Q4 2022 and Q1 2023 as a number of Trials are ending in Q3 and Q4 2022. We expect to be in negotiations for Commercial Technology Purchases and related contracted sales with growers after full analyses of their Trial results and value accretion during Q4 2022 and Q1 2023



<< Previous
Bullboard Posts
Next >>